ROCHESTER, N.Y., April 14 /PRNewswire/ -- Bio-Optronics, Inc. and flexcipio s.a. are pleased to announce an agreement to cross-market and integrate Bio-Optronics' Clinical Conductor Clinical Trial Management System (CTMS) and flexcipio's eClinical Electronic Data Capture (EDC) solution. This aligns the industry's most comprehensive enterprise CTMS, with an innovative EDC, to provide clinical research with the best tools to optimize efficiency, productivity, and improve collaboration across the clinical environment. Clinical Conductor CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly.
Dan Kerpelman, Bio-Optronics President and CEO states, "Our extensive workflow expertise is a perfect match to flexcipio's data capture expertise." Pierre Ghyssens, flexcipio General Manager adds "Both our companies are dedicated to developing the latest solutions. By combining forces, we are able to provide a unique, global offering to the health sector."
Clinical Conductor CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting. The academic medical center CTMS solution adds research administration capabilities and custom interfaces to hospital enterprise systems.
eClinical EDC delivers powerful functionality and flexibility through a rich, interactive, user-friendly web-browser interface. EDC features include database definition, form design, QA process set-up, and powerful reporting. And, users are empowered to adapt the electronic data capture environment, intuitively. Qualified to the highest quality standards, data integrity and security are ensured, along with CDISC compliance.
Bio-Optronics, Inc. develops, deploys, and
|SOURCE Bio-Optronics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved